Aprogen Biologics Inc. (KRX:003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,175.00
-35.00 (-1.09%)
At close: May 21, 2026
Market Cap42.28B -72.6%
Revenue (ttm)73.23B +8.7%
Net Income-170.33B
EPS-12,931.73
Shares Out13.17M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume317,702
Average Volume614,535
Open3,210.00
Previous Close3,210.00
Day's Range3,060.00 - 3,305.00
52-Week Range2,745.00 - 10,770.00
Beta-0.17
RSI40.07
Earnings DateMay 20, 2026

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1960
Employees 391
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

In 2025, Aprogen Biologics's revenue was 73.23 billion, an increase of 8.68% compared to the previous year's 67.38 billion. Losses were -170.33 billion, 62.3% more than in 2024.

Financial Statements